<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-id journal-id-type="iso-abbrev">Environ. Health Perspect</journal-id><journal-title-group><journal-title>Environmental Health Perspectives</journal-title></journal-title-group><issn pub-type="ppub">0091-6765</issn><issn pub-type="epub">1552-9924</issn><publisher><publisher-name>National Institue of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15289156</article-id><article-id pub-id-type="pmc">1247471</article-id><article-id pub-id-type="doi">10.1289/ehp.7028</article-id><article-id pub-id-type="publisher-id">ehp0112-001137</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject><subj-group><subject>Commentaries</subject></subj-group></subj-group></article-categories><title-group><article-title>The Need to Decide If All Estrogens Are Intrinsically Similar</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Moggs</surname><given-names>Jonathan G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ashby</surname><given-names>John</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tinwell</surname><given-names>Helen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Fei Ling</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moore</surname><given-names>David J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kimber</surname><given-names>Ian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Orphanides</surname><given-names>George</given-names></name></contrib></contrib-group><aff>Syngenta CTL, Alderley Park, Cheshire, United Kingdom</aff><author-notes><corresp id="fn1-ehp0112-001137">Address correspondence to J.G. Moggs, Syngenta CTL, Alderley Park, Cheshire, SK10 4TJ UK. Telephone: 44-1625-519315. Fax: 44-1625-585715. E-mail:
jonathan.moggs@syngenta.com</corresp><fn><p>We thank A. Soames for the histopathology data, I. Kupershmidt and E. Hunter (Silicon Genetics) for advice on statistical analysis of microarray data, and T. Barlow (Food Standards Agency) for critical comments.</p></fn><fn><p>This work was partially supported by the U.K. Food Standards Agency.</p></fn><fn><p>The authors declare they have no competing financial interests.</p></fn></author-notes><pub-date pub-type="ppub"><month>8</month><year>2004</year></pub-date><pub-date pub-type="epub"><day>19</day><month>5</month><year>2004</year></pub-date><volume>112</volume><issue>11</issue><fpage>1137</fpage><lpage>1142</lpage><history><date date-type="received"><day>12</day><month>2</month><year>2004</year></date><date date-type="accepted"><day>19</day><month>5</month><year>2004</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/mark/1.0/" license-type="public-domain"><license-p>Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. </license-p></license></permissions><abstract><p>We used gene expression profiling to investigate whether the molecular effects induced by estrogens of different provenance are intrinsically similar. In this article we show that the physiologic estrogen 17&#x003b2;-estradiol, the phytoestrogen genistein, and the synthetic estrogen diethylstilbestrol alter the expression of the same 179 genes in the intact immature mouse uterus under conditions where each chemical has produced an equivalent gravimetric and histologic uterotrophic effect, using the standard 3-day assay protocol. Data are also presented indicating the limitations associated with comparison of gene expression profiles for different chemicals at times before the uterotrophic effects are fully realized. We conclude that the case has yet to be made for regarding synthetic estrogens as presenting a unique human hazard compared with phytoestrogens and physiologic estrogens.</p></abstract><kwd-group><kwd>diethylstilbestrol</kwd><kwd>estrogen</kwd><kwd>gene expression</kwd><kwd>genistein</kwd><kwd>microarray</kwd><kwd>phytoestrogen</kwd><kwd>toxicogenomics</kwd><kwd>uterus</kwd></kwd-group></article-meta></front><body><p>The question of whether phytoestrogens and synthetic estrogens are toxicologically similar, or intrinsically different, presents a challenge to all involved in human hazard and risk assessments. Although there is a general concern that exposure to nanogram or microgram amounts of environmental estrogens may be associated with adverse health effects, in the public mind there is a widespread belief that foods and dietary supplements containing milligram quantities of phytoestrogens confer only health benefits. An implicit distinction therefore seems to have been drawn between synthetic and plant-derived estrogens&#x02014;a belief sustained in the public mind by the assumption that natural is good and synthetic is bad&#x02014;but an untested and potentially misleading notion for those involved with science-based human hazard/risk assessments.</p><p>Phytoestrogens and synthetic estrogens are generally considered separately in the literature. For example, <xref ref-type="bibr" rid="b18-ehp0112-001137">Howdeshell et al. (1999)</xref> suggested a possible association between the advance in first estrus observed in mice exposed <italic>in utero</italic> to 2.4 &#x003bc;g/kg of the synthetic environmental estrogen bisphenol A and reports of an increased incidence of hypospadias in boys (<xref ref-type="bibr" rid="b32-ehp0112-001137">Paulozzi et al. 1997</xref>) and the earlier sexual maturation of girls (<xref ref-type="bibr" rid="b15-ehp0112-001137">Herman-Giddens et al. 1997</xref>)&#x02014;the implication being that synthetic estrogens present a greater hazard than the much higher levels of phytoestrogens being consumed by those same children. In contrast, there are reports of an increased incidence of hypospadias in boys born to vegetarians (<xref ref-type="bibr" rid="b27-ehp0112-001137">North and Golding 2000</xref>), of alterations in the menstrual cycle (<xref ref-type="bibr" rid="b6-ehp0112-001137">Cassidy et al. 1994</xref>), and of reduced breast cancer incidences (<xref ref-type="bibr" rid="b22-ehp0112-001137">Messina 1999</xref>) among women eating diets rich in phytoestrogens. Support for these epidemiologic observations comes from experimental studies indicating that advances in sexual development in rodents can be induced by their exposure to phytoestrogens (<xref ref-type="bibr" rid="b5-ehp0112-001137">Casanova et al. 1999</xref>; <xref ref-type="bibr" rid="b7-ehp0112-001137">Cassidy and Faughnan 2000</xref>; <xref ref-type="bibr" rid="b34-ehp0112-001137">Safe et al. 2002</xref>). In contrast to these separate lines of inquiry, Newbold and colleagues have evaluated potential similarities between natural and synthetic estrogens. In seminal studies, they demonstrated that neonatal exposure of female mice to equipotent uterotrophic doses of the phytoestrogen genistein (GEN; <xref ref-type="fig" rid="f1-ehp0112-001137">Figure 1</xref>) or the synthetic estrogen diethylstilbestrol (DES) leads to an identical incidence of uterine adenomas at 18 months of age (<xref ref-type="bibr" rid="b26-ehp0112-001137">Newbold et al. 2001</xref>). However, in attempting to draw parallels, or distinctions, between phytoestrogens and synthetic estrogens, it is imperative to consider growing awareness of the complexity of estrogen signaling pathway and the pleuripotential biologic activities of most organic chemicals&#x02014;irrespective of their origin.</p><p>Estrogen signaling in mammalian cells is primarily mediated at the molecular level by two members of the nuclear receptor superfamily&#x02014;estrogen receptors alpha (ER-&#x003b1;) and beta (ER-&#x003b2;). Ligand-activated ER-&#x003b1; and ER-&#x003b2; function as transcription factors, in conjunction with numerous coregulatory proteins, in order to activate or repress the transcription of ER-responsive genes (<xref ref-type="bibr" rid="b14-ehp0112-001137">Hall et al. 2001</xref>; <xref ref-type="bibr" rid="b23-ehp0112-001137">Moggs and Orphanides 2001</xref>). There is considerable variation in the binding affinity of ER-&#x003b1; and ER-&#x003b2; among different estrogens (<xref ref-type="bibr" rid="b19-ehp0112-001137">Kuiper et al. 1998</xref>). In the case of the chemicals studied here, the physiologic estrogen 17&#x003b2;-estradiol (E<sub>2</sub>) and DES bind with a similar affinity to ER-&#x003b1; and ER-&#x003b2;, whereas GEN binds with approximately 20-fold higher affinity to ER-&#x003b2; than to ER-&#x003b2; (<xref ref-type="bibr" rid="b19-ehp0112-001137">Kuiper et al. 1998</xref>). Concerning nonhormonal properties of the test chemicals (most of which have only be defined <italic>in vitro</italic>), GEN inhibits a range of enzymes, including tyrosine kinases (<xref ref-type="bibr" rid="b2-ehp0112-001137">Akiyama et al. 1987</xref>), nitric oxide synthase (<xref ref-type="bibr" rid="b10-ehp0112-001137">Duarte et al. 1997</xref>), and topoisomerase II (<xref ref-type="bibr" rid="b29-ehp0112-001137">Okura et al. 1988</xref>), and also decreases calcium-channel activity (<xref ref-type="bibr" rid="b33-ehp0112-001137">Potier and Rovira 1999</xref>), lipid peroxidation (<xref ref-type="bibr" rid="b4-ehp0112-001137">Arora et al. 1998</xref>), and diacylglycerol synthesis (<xref ref-type="bibr" rid="b9-ehp0112-001137">Dean et al. 1989</xref>). Likewise, DES is reported to induce aneuploidy in mammalian cells (<xref ref-type="bibr" rid="b1-ehp0112-001137">Aardema et al. 1998</xref>) and to bind to rat liver DNA (<xref ref-type="bibr" rid="b39-ehp0112-001137">Williams et al. 1993</xref>). More recently, some phytoestrogens were reported to inhibit the aromatase-mediated conversion of testosterone to E<sub>2</sub>
<italic>in vitro</italic> (<xref ref-type="bibr" rid="b3-ehp0112-001137">Almstrup et al. 2002</xref>), and equol, the major circulating estrogenic metabolite associated with the dietary ingestion of phytoestrogens, is reported to selectively sequester dihydrotestosterone and thereby to act as a functional antiandrogen <italic>in vivo</italic> (<xref ref-type="bibr" rid="b21-ehp0112-001137">Lund et al. 2004</xref>).</p><p>In order to advance understanding in this area, we decided to compare the genes expressed in the immature mouse uterus when it had grown in response to treatment with the estrogens E<sub>2</sub>, DES, and GEN. The immature mouse uterus was selected for our analysis because it is a major estrogen-responsive organ and forms the basis for a reference assay of estrogenic activity (<xref ref-type="bibr" rid="b31-ehp0112-001137">Owens and Ashby 2002</xref>), including carcinogenesis (<xref ref-type="bibr" rid="b26-ehp0112-001137">Newbold et al. 2001</xref>). Furthermore, it expresses both ER-&#x003b1; and ER-&#x003b2; (<xref ref-type="bibr" rid="b38-ehp0112-001137">Weihua et al. 2000</xref>) and the androgen receptor (<xref ref-type="bibr" rid="b11-ehp0112-001137">Frasor et al. 2003</xref>). We initially conducted a global analysis of gene expression in the mouse uterus at 1, 2, 4, 8, 24, 48, and 72 hr after exposure to a single high dose of either GEN (250 mg/kg) or E<sub>2</sub> (400 &#x003bc;g/kg). These single high doses yielded a sustained uterotrophic response over 72 hr (<xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2A</xref>) and were selected to avoid the complex transcriptional program that may result from the standard uterotrophic assay exposure regime in which each test compound is dosed by repeated administration on 3 consecutive days (Odum et al. 1997). Groups of 10 sexually immature mice [Alpk:APfCD-1; 19/20 days of age; maintained on RM1 diet (Special Diets Services Ltd., Witham, Essex, UK)] received a single subcutaneous injection of each compound or the test vehicle [arachis oil (AO); 5 mL/kg], and uterine RNA was isolated and pooled by group at each of the seven time points to determine gene expression levels among the 12,488 mouse genes represented on the Affymetrix MG-U74Av2 GeneChip (Affymetrix, High Wycombe, UK). Transcript profiling was performed using MG-U74Av2 GeneChip and Microarray Analysis Suite 5.0 (Affymetrix). Normalization and hierarchical clustering were performed with GeneSpring 6.0 (Silicon Genetics, Redwood City, CA, USA). MIAME (<italic>Minimum Information About a Microarray Experiment</italic>)-compliant microarray data are available as supplementary information and submitted to the Gene Expression Omnibus (GEO) database (<xref ref-type="bibr" rid="b13-ehp0112-001137">GEO 2004</xref>). These data were analyzed using unsupervised hierarchical clustering and yielded temporal relationships between the expression profiles of 3,450 genes that were either up- or down-regulated (&#x0003e; 1.5-fold) by E<sub>2</sub> and/or GEN (<xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2B</xref>). Each chemical induced a similar, multistage transcriptional response (<xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2B</xref>), although it is noteworthy that we observed variations in the magnitude and timing of both early (e.g., c-<italic>fos</italic>) and late (e.g., lactotransferrin) ER-responsive genes during the uterotrophic responses induced by E<sub>2</sub> and GEN (<xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2C</xref>).</p><p>A detailed description of the molecular functions of the genes affected, together with their association with physiologic changes during uterine growth, has been reported (<xref ref-type="bibr" rid="b30-ehp0112-001137">Orphanides et al. 2003</xref>) and will be described in more detail in a future publication (Moggs et al., unpublished data).</p><p>These observations suggest that GEN does not induce &#x0201c;off-target&#x0201d; ER-independent transcriptional responses, that is, those associated with the properties of GEN other than estrogenicity. Furthermore, there was no evidence for the topoisomerase II&#x02013;inhibiting properties of GEN in the bone marrow of the present mice despite demonstration of the sensitivity of that tissue to the potent micronucleus-inducing activity of the topoisomerase II inhibitor etoposide (data not shown). Together, these data led us to question whether a synthetic estrogen such as DES would also induce similar transcriptional responses in the immature mouse uterus.</p><p>In order to avoid temporal vagaries in gene expression (e.g., <xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2C</xref>), we decided to anchor our transcript profiling data to the phenotype of the grown uterus by employing equipotent uterotrophic doses of E<sub>2</sub>, GEN, and DES. We compared the global gene expression profiles in the uteri of intact immature mice stimulated with three daily low doses of either GEN, DES, or E<sub>2</sub>, with an exposure regimen the same as that used in a standard 3-day uterotrophic assay (Odum et al. 1997). The route of administration and the doses of GEN and DES used were as described by <xref ref-type="bibr" rid="b26-ehp0112-001137">Newbold et al. (2001)</xref> in their equivalent-outcome carcinogenicity bioassays of these two chemicals. Three independent replicates of four groups of sexually immature mice (Alpk:APfCD-1; 19/20 days of age; maintained on RM1 diet) received three daily subcutaneous injections of GEN (50 mg/kg), E<sub>2</sub> (2.5 &#x003bc;g/kg), or DES (2 &#x003bc;g/kg). Control animals received the vehicle, AO (5 mL/kg). These doses elicited similar uterotrophic responses (72 hr after the initial dose; <xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3A</xref>, <xref ref-type="table" rid="t1-ehp0112-001137">Table 1</xref>) and identical histologic changes in the uteri of the treated animals (<xref ref-type="table" rid="t1-ehp0112-001137">Table 1</xref>). Uterine RNA was isolated and pooled for each of the 12 groups and analyzed for changes in gene expression levels using the same Affymetrix microarray of 12,488 mouse genes. The data were analyzed using two independent statistical methods. First, unsupervised hierarchical clustering defined the global relationships (Euclidean distances) between the 12 gene expression profiles (<xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3B</xref>). The three control groups clustered under one node, whereas the chemical treatment groups formed a separate node of compound-independent clusters, indicating equal similarity within and between the transcriptional responses induced by the three estrogens (<xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3B</xref>). One-way analysis of variance (ANOVA), with Bonferroni (<xref ref-type="bibr" rid="b17-ehp0112-001137">Holm 1979</xref>) correction (familywise error rate &#x0003c; 0.05) to minimize false positives, identified 179 genes where expression levels were altered by one or more chemical treatments (<xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3C</xref>). Remarkably, Tukey post hoc testing revealed that all of these genes were affected in all nine compound treatment groups.</p><p><xref ref-type="table" rid="t2-ehp0112-001137">Table 2</xref> highlights the high degree of similarity between the transcriptional responses to each of the three estrogens. These include established estrogen-responsive genes such as lactotransferrin, complement component 3, c<italic>-fos</italic>, small proline-rich protein 2A, and keratoepithelin (<xref ref-type="bibr" rid="b16-ehp0112-001137">Hewitt et al. 2003</xref>; <xref ref-type="bibr" rid="b25-ehp0112-001137">Naciff et al. 2003</xref>), together with many genes that have not previously been associated with estrogenicity (<xref ref-type="table" rid="t2-ehp0112-001137">Table 2</xref>).</p><p>Although these three estrogens can alter the expression of some genes with different magnitudes [e.g., peptidyl arginine deiminase II is up-regulated to a lesser extent by E<sub>2</sub> (1.86-fold &#x000b1; 0.27) relative to GEN (9.11-fold &#x000b1; 0.33) and DES (5.15-fold &#x000b1; 1.53); <xref ref-type="table" rid="t2-ehp0112-001137">Table 2</xref>], the present data show that the same genes are affected during equivalent uterotrophic responses. Previous studies have revealed both similarities and differences between transcriptional responses induced at a single time point after exposure to E<sub>2</sub> and DES in the uteri of immature ovariectomized mice (<xref ref-type="bibr" rid="b37-ehp0112-001137">Watanabe et al. 2003</xref>) and after exposure to either GEN, bisphenol A, or 17&#x003b1;-ethynyl estradiol in the reproductive tract of intact adult rats (<xref ref-type="bibr" rid="b24-ehp0112-001137">Naciff et al. 2002</xref>). We suggest that these reported differences most probably arise from dose-dependent variations in the magnitude and kinetics of gene expression (<xref ref-type="fig" rid="f2-ehp0112-001137">Figure 2C</xref>), rather than from the operation of distinct mechanisms of estrogenic action.</p><p>Our data indicate that estrogens of differing provenance may have in common the potential for both beneficial and adverse health effects. This highlights the need for an holistic approach to hazard assessment wherein preconceptions are replaced by an objective assessment of the likely perturbations of physiologic functions caused by combined exposures to physiologic, synthetic, and plant-derived estrogens. This need is reinforced by data showing that plasma concentrations of isoflavones in infants fed soy formula are approximately 200 times higher than for those fed human milk (<xref ref-type="bibr" rid="b35-ehp0112-001137">Setchell et al. 1997</xref>), by the estimated daily intake of approximately 29 mg of phytoestrogens for individuals taking dietary supplements (<xref ref-type="bibr" rid="b8-ehp0112-001137">Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment 2003</xref>), and by the demonstration that estrogens of different provenance can act additively in the rodent uterus (<xref ref-type="bibr" rid="b36-ehp0112-001137">Tinwell and Ashby 2004</xref>).</p></body><back><ref-list><title>References</title><ref id="b1-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Aardema</surname><given-names>MJ</given-names></name><name><surname>Albertini</surname><given-names>S</given-names></name><name><surname>Arni</surname><given-names>P</given-names></name><name><surname>Henderson</surname><given-names>LM</given-names></name><name><surname>Kirsch-Volders</surname><given-names>M</given-names></name><name><surname>Mackay</surname><given-names>JM</given-names></name><etal/></person-group><year>1998</year><article-title>Aneuploidy: a report of an ECETOC task force</article-title><source>Mutat Res</source><volume>410</volume><fpage>3</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">9587424</pub-id></element-citation></ref><ref id="b2-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>J</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Ogawara</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><etal/></person-group><year>1987</year><article-title>Genistein, a specific inhibitor of tyrosine-specific protein kinases</article-title><source>J Biol Chem</source><volume>262</volume><fpage>5592</fpage><lpage>5595</lpage><pub-id pub-id-type="pmid">3106339</pub-id></element-citation></ref><ref id="b3-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Almstrup</surname><given-names>K</given-names></name><name><surname>Fernandez</surname><given-names>MF</given-names></name><name><surname>Petersen</surname><given-names>JH</given-names></name><name><surname>Olea</surname><given-names>N</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name></person-group><year>2002</year><article-title>Dual effects of phytoestrogens result in U-shaped dose&#x02013;response curves</article-title><source>Environ Health Perspect</source><volume>110</volume><fpage>743</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">12153753</pub-id></element-citation></ref><ref id="b4-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Arora</surname><given-names>A</given-names></name><name><surname>Nair</surname><given-names>MG</given-names></name><name><surname>Strasburg</surname><given-names>GM</given-names></name></person-group><year>1998</year><article-title>Antioxidant activities of isoflavones and their biological metabolites in a liposomal system</article-title><source>Arch Biochem Biophys</source><volume>356</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">9705203</pub-id></element-citation></ref><ref id="b5-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Casanova</surname><given-names>M</given-names></name><name><surname>You</surname><given-names>L</given-names></name><name><surname>Gaido</surname><given-names>KW</given-names></name><name><surname>Archibeque-Engle</surname><given-names>S</given-names></name><name><surname>Janszen</surname><given-names>DB</given-names></name><name><surname>Heck</surname><given-names>HA</given-names></name></person-group><year>1999</year><article-title>Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors &#x003b1; and &#x003b2; <italic>in vitro</italic></article-title><source>Toxicol Sci</source><volume>51</volume><fpage>236</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">10543025</pub-id></element-citation></ref><ref id="b6-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Cassidy</surname><given-names>A</given-names></name><name><surname>Bingham</surname><given-names>S</given-names></name><name><surname>Setchell</surname><given-names>KDR</given-names></name></person-group><year>1994</year><article-title>Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women</article-title><source>Am J Clin Nutr</source><volume>60</volume><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">8074062</pub-id></element-citation></ref><ref id="b7-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Cassidy</surname><given-names>A</given-names></name><name><surname>Faughnan</surname><given-names>M</given-names></name></person-group><year>2000</year><article-title>Phyto-oestrogens through the life cycle</article-title><source>Proc Nutr Soc</source><volume>59</volume><fpage>489</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">10997682</pub-id></element-citation></ref><ref id="b8-ehp0112-001137"><mixed-citation publication-type="other"><collab>Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment</collab> 2003. Phytoestrogens and Health. London:Food Standards Agency. Available: <ext-link ext-link-type="uri" xlink:href="http://www.foodstandards.gov.uk/multimedia/pdfs/phytoreport0503">http://www.foodstandards.gov.uk/multimedia/pdfs/phytoreport0503</ext-link> [accessed 2 June 2004].</mixed-citation></ref><ref id="b9-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Dean</surname><given-names>NM</given-names></name><name><surname>Kanemitsu</surname><given-names>M</given-names></name><name><surname>Boynton</surname><given-names>AL</given-names></name></person-group><year>1989</year><article-title>Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells</article-title><source>Biochem Biophys Res Commun</source><volume>165</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">2532009</pub-id></element-citation></ref><ref id="b10-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Duarte</surname><given-names>J</given-names></name><name><surname>Ocete</surname><given-names>MA</given-names></name><name><surname>Perez-Vizcaino</surname><given-names>F</given-names></name><name><surname>Zarzuelo</surname><given-names>A</given-names></name><name><surname>Tamargo</surname><given-names>J</given-names></name></person-group><year>1997</year><article-title>Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase</article-title><source>Eur J Pharmacol</source><volume>338</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9408000</pub-id></element-citation></ref><ref id="b11-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Frasor</surname><given-names>J</given-names></name><name><surname>Barnett</surname><given-names>DH</given-names></name><name><surname>Danes</surname><given-names>JM</given-names></name><name><surname>Hess</surname><given-names>R</given-names></name><name><surname>Parlow</surname><given-names>AF</given-names></name><name><surname>Katzenellenbogen</surname><given-names>BS</given-names></name></person-group><year>2003</year><article-title>Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) &#x003b1; activity by ER&#x003b2; in the uterus</article-title><source>Endocrinology</source><volume>144</volume><fpage>3159</fpage><lpage>3166</lpage><pub-id pub-id-type="pmid">12810572</pub-id></element-citation></ref><ref id="b12-ehp0112-001137"><mixed-citation publication-type="other"><collab>Genbank</collab> 2004. Bethesda, MD:National Center for Biotechnology Information, National Library of Medicine. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/GenbankOverview.html">http://www.ncbi.nlm.nih.gov/Genbank/GenbankOverview.html</ext-link> [accessed 2 June 2004].</mixed-citation></ref><ref id="b13-ehp0112-001137"><mixed-citation publication-type="other"><collab>GEO</collab> 2004. Gene Expression Omnibus Homepage. Bethesda, MD:National Center for Biotechnology Information, National Library of Medicine. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link> [accessed 2 June 2004].</mixed-citation></ref><ref id="b14-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Hall</surname><given-names>JM</given-names></name><name><surname>Couse</surname><given-names>JF</given-names></name><name><surname>Korach</surname><given-names>KS</given-names></name></person-group><year>2001</year><article-title>The multifaceted mechanisms of estradiol and estrogen receptor signaling</article-title><source>J Biol Chem</source><volume>276</volume><fpage>36869</fpage><lpage>36872</lpage><pub-id pub-id-type="pmid">11459850</pub-id></element-citation></ref><ref id="b15-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Herman-Giddens</surname><given-names>ME</given-names></name><name><surname>Slora</surname><given-names>EJ</given-names></name><name><surname>Wasserman</surname><given-names>RC</given-names></name><name><surname>Bourdony</surname><given-names>CJ</given-names></name><name><surname>Bhapkar</surname><given-names>MV</given-names></name><name><surname>Koch</surname><given-names>GG</given-names></name><etal/></person-group><year>1997</year><article-title>Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network</article-title><source>Pediatrics</source><volume>99</volume><fpage>505</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">9093289</pub-id></element-citation></ref><ref id="b16-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Hewitt</surname><given-names>SC</given-names></name><name><surname>Deroo</surname><given-names>BJ</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Grissom</surname><given-names>S</given-names></name><name><surname>Afshari</surname><given-names>CA</given-names></name><etal/></person-group><year>2003</year><article-title>Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen</article-title><source>Mol Endocrinol</source><volume>17</volume><fpage>2070</fpage><lpage>2083</lpage><pub-id pub-id-type="pmid">12893882</pub-id></element-citation></ref><ref id="b17-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Holm</surname><given-names>S</given-names></name></person-group><year>1979</year><article-title>A simple sequentially rejective Bonferroni test procedure</article-title><source>Scand J Stat</source><volume>6</volume><fpage>65</fpage><lpage>70</lpage></element-citation></ref><ref id="b18-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Howdeshell</surname><given-names>KL</given-names></name><name><surname>Hotchkiss</surname><given-names>AK</given-names></name><name><surname>Thayer</surname><given-names>KA</given-names></name><name><surname>Vandenbergh</surname><given-names>JG</given-names></name><name><surname>vom Saal</surname><given-names>FS</given-names></name></person-group><year>1999</year><article-title>Exposure to bisphenol A advances puberty</article-title><source>Nature</source><volume>401</volume><fpage>763</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">10548101</pub-id></element-citation></ref><ref id="b19-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Kuiper</surname><given-names>GG</given-names></name><name><surname>Lemmen</surname><given-names>JG</given-names></name><name><surname>Carlsson</surname><given-names>B</given-names></name><name><surname>Corton</surname><given-names>JC</given-names></name><name><surname>Safe</surname><given-names>SH</given-names></name><name><surname>van der Saag</surname><given-names>PT</given-names></name><etal/></person-group><year>1998</year><article-title>Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor &#x003b2;</article-title><source>Endocrinology</source><volume>139</volume><fpage>4252</fpage><lpage>4263</lpage><pub-id pub-id-type="pmid">9751507</pub-id></element-citation></ref><ref id="b20-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Loraine</surname><given-names>AE</given-names></name><name><surname>Shigeta</surname><given-names>R</given-names></name><name><surname>Cline</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Valmeekam</surname><given-names>V</given-names></name><etal/></person-group><year>2003</year><article-title>NetAffx: Affymetrix probesets and annotations</article-title><source>Nucleic Acids Res</source><volume>31</volume><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">12519953</pub-id></element-citation></ref><ref id="b21-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Lund</surname><given-names>TD</given-names></name><name><surname>Munson</surname><given-names>DJ</given-names></name><name><surname>Haldy</surname><given-names>ME</given-names></name><name><surname>Setchell</surname><given-names>KD</given-names></name><name><surname>Lephart</surname><given-names>ED</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group><year>2004</year><article-title>Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback</article-title><source>Biol Reprod</source><volume>70</volume><fpage>1188</fpage><lpage>1195</lpage><pub-id pub-id-type="pmid">14681200</pub-id></element-citation></ref><ref id="b22-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Messina</surname><given-names>MJ</given-names></name></person-group><year>1999</year><article-title>Legumes and soybeans: overview of their nutritional profiles and health effects</article-title><source>Am J Clin Nutr</source><volume>70</volume><fpage>439S</fpage><lpage>450S</lpage><pub-id pub-id-type="pmid">10479216</pub-id></element-citation></ref><ref id="b23-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Moggs</surname><given-names>JG</given-names></name><name><surname>Orphanides</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Estrogen receptors: orchestrators of pleiotropic cellular responses</article-title><source>EMBO Rep</source><volume>9</volume><fpage>775</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">11559590</pub-id></element-citation></ref><ref id="b24-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Naciff</surname><given-names>JM</given-names></name><name><surname>Jump</surname><given-names>ML</given-names></name><name><surname>Torontali</surname><given-names>SM</given-names></name><name><surname>Carr</surname><given-names>GJ</given-names></name><name><surname>Tiesman</surname><given-names>JP</given-names></name><name><surname>Overmann</surname><given-names>GJ</given-names></name><etal/></person-group><year>2002</year><article-title>Gene expression profile induced by 17&#x003b1;-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat</article-title><source>Toxicol Sci</source><volume>68</volume><fpage>184</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">12075121</pub-id></element-citation></ref><ref id="b25-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Naciff</surname><given-names>JM</given-names></name><name><surname>Overmann</surname><given-names>GJ</given-names></name><name><surname>Torontali</surname><given-names>SM</given-names></name><name><surname>Carr</surname><given-names>GJ</given-names></name><name><surname>Tiesman</surname><given-names>JP</given-names></name><name><surname>Richardson</surname><given-names>BD</given-names></name><etal/></person-group><year>2003</year><article-title>Gene expression profile induced by 17&#x003b1;-ethynyl estradiol in the prepubertal female reproductive system of the rat</article-title><source>Toxicol Sci</source><volume>72</volume><fpage>314</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">12655037</pub-id></element-citation></ref><ref id="b26-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Newbold</surname><given-names>RR</given-names></name><name><surname>Banks</surname><given-names>EP</given-names></name><name><surname>Bullock</surname><given-names>B</given-names></name><name><surname>Jefferson</surname><given-names>WN</given-names></name></person-group><year>2001</year><article-title>Uterine adenocarcinoma in mice treated neonatally with genistein</article-title><source>Cancer Res</source><volume>61</volume><fpage>4325</fpage><lpage>4328</lpage><pub-id pub-id-type="pmid">11389053</pub-id></element-citation></ref><ref id="b27-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>North</surname><given-names>K</given-names></name><name><surname>Golding</surname><given-names>J</given-names></name></person-group><year>2000</year><article-title>A maternal vegetarian diet in pregnancy is associated with hypospadias</article-title><source>Br J Urol Int</source><volume>85</volume><fpage>107</fpage><lpage>113</lpage></element-citation></ref><ref id="b28-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Odum</surname><given-names>J</given-names></name><name><surname>Lefevre</surname><given-names>PA</given-names></name><name><surname>Tittensor</surname><given-names>S</given-names></name><name><surname>Paton</surname><given-names>D</given-names></name><name><surname>Routledge</surname><given-names>ED</given-names></name><name><surname>Beresford</surname><given-names>NA</given-names></name><etal/></person-group><article-title>The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay</article-title><source>Regul Toxicol Pharmacol</source><volume>25</volume><fpage>176</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">9185893</pub-id></element-citation></ref><ref id="b29-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Okura</surname><given-names>A</given-names></name><name><surname>Arakawa</surname><given-names>H</given-names></name><name><surname>Oka</surname><given-names>H</given-names></name><name><surname>Yoshinari</surname><given-names>T</given-names></name><name><surname>Monden</surname><given-names>Y</given-names></name></person-group><year>1988</year><article-title>Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-<italic>ras</italic>-transformed NIH 3T3 cells</article-title><source>Biochem Biophys Res Commun</source><volume>157</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">2848517</pub-id></element-citation></ref><ref id="b30-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Orphanides</surname><given-names>G</given-names></name><name><surname>Moggs</surname><given-names>JG</given-names></name><name><surname>Spurway</surname><given-names>T</given-names></name><name><surname>Tinwell</surname><given-names>H</given-names></name><name><surname>Ashby</surname><given-names>J</given-names></name><name><surname>Kimber</surname><given-names>I</given-names></name></person-group><year>2003</year><article-title>Use of gene expression profiling to understand the transcriptional programme associated with estrogen-induced uterine growth: implications for the use of surrogate molecular markers in toxicology [Abstract]</article-title><source>Toxicol Sci</source><volume>72</volume><fpage>12</fpage></element-citation></ref><ref id="b31-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Owens</surname><given-names>JW</given-names></name><name><surname>Ashby</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development</article-title><source>Crit Rev Toxicol</source><volume>32</volume><fpage>445</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">12487363</pub-id></element-citation></ref><ref id="b32-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Paulozzi</surname><given-names>LJ</given-names></name><name><surname>Erickson</surname><given-names>JD</given-names></name><name><surname>Jackson</surname><given-names>RJ</given-names></name></person-group><year>1997</year><article-title>Hypospadias: trends in two US surveillance systems</article-title><source>Pediatrics</source><volume>100</volume><fpage>831</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">9346983</pub-id></element-citation></ref><ref id="b33-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Potier</surname><given-names>B</given-names></name><name><surname>Rovira</surname><given-names>C</given-names></name></person-group><year>1999</year><article-title>Protein tyrosine kinase inhibitors reduce high-voltage activating calcium currents in CA1 pyramidal neurones from rat hippocampal slices</article-title><source>Brain Res</source><volume>816</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">9878884</pub-id></element-citation></ref><ref id="b34-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Safe</surname><given-names>SH</given-names></name><name><surname>Pallaroni</surname><given-names>L</given-names></name><name><surname>Yoon</surname><given-names>K</given-names></name><name><surname>Gaido</surname><given-names>K</given-names></name><name><surname>Ross</surname><given-names>S</given-names></name><name><surname>McDonnell</surname><given-names>D</given-names></name></person-group><year>2002</year><article-title>Problems for risk assessment of endocrine-active estrogenic compounds</article-title><source>Environ Health Perspect</source><volume>110</volume><fpage>925</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">12634121</pub-id></element-citation></ref><ref id="b35-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Setchell</surname><given-names>KDR</given-names></name><name><surname>Zimmer-Nechemias</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Heubi</surname><given-names>JE</given-names></name></person-group><year>1997</year><article-title>Exposure of infants to phyto-oestrogens from soy-based infant formula</article-title><source>Lancet</source><volume>350</volume><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">9217716</pub-id></element-citation></ref><ref id="b36-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Tinwell</surname><given-names>H</given-names></name><name><surname>Ashby</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens</article-title><source>Environ Health Perspect</source><volume>112</volume><fpage>575</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">15064164</pub-id></element-citation></ref><ref id="b37-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Lubahn</surname><given-names>DB</given-names></name><name><surname>Handa</surname><given-names>H</given-names></name><name><surname>Iguchi</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Similarities and differences in uterine gene expression patterns caused by treatment with physiological and non-physiological estrogens</article-title><source>J Mol Endocrinol</source><volume>3</volume><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">14664709</pub-id></element-citation></ref><ref id="b38-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Weihua</surname><given-names>Z</given-names></name><name><surname>Saji</surname><given-names>S</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>EV</given-names></name><name><surname>Warner</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Estrogen receptor (ER) &#x003b2;, a modulator of ER&#x003b1; in the uterus</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>5936</fpage><lpage>5941</lpage><pub-id pub-id-type="pmid">10823946</pub-id></element-citation></ref><ref id="b39-ehp0112-001137"><element-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>GM</given-names></name><name><surname>Iatropoulos</surname><given-names>M</given-names></name><name><surname>Cheung</surname><given-names>R</given-names></name><name><surname>Radi</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>CX</given-names></name></person-group><year>1993</year><article-title>Diethylstilbestrol liver carcinogenicity and modification of DNA in rats</article-title><source>Cancer Lett</source><volume>68</volume><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">8443792</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ehp0112-001137" position="float"><label>Figure 1</label><caption><title>Chemical structure of GEN, E<sub>2</sub>, and DES.</title></caption><graphic xlink:href="ehp0112-001137f1"/></fig><fig id="f2-ehp0112-001137" position="float"><label>Figure 2</label><caption><title>Induction of very similar multistage transcriptional responses in the mouse uterus by E<sub>2</sub> and GEN. (<italic>A</italic>) Blotted uterine weights (mean &#x000b1; SD) of sexually immature mice (<italic>n</italic> = 10/group) at different times after a single subcutaneous dose of E<sub>2</sub> (400 &#x003bc;g/kg), GEN (250 mg/kg), or AO (control; 5 mL/kg). See text for details of experiments. (<italic>B</italic>) Temporal expression profiles of 3,450 genes up-regulated or repressed (&#x0003e; 1.5-fold) by either E<sub>2</sub> (400 &#x003bc;g/kg) or GEN (250 mg/kg) at one or more of seven different time points. The magnitude of altered gene expression (fold change vs. time-matched vehicle control) is indicated by color; genes are grouped according to similarity of their temporal expression profiles (Pearson correlation-based hierarchical clustering). (<italic>C</italic>) Northern blot analysis of temporal expression pattern of early (c-<italic>fos</italic>) and late (lactotransferrin) estrogen-responsive genes; the fold induction of gene expression relative to time-matched vehicle controls was calculated after data were normalized to the expression of the control gene <italic>RPB1</italic> (accession number NM_009089).
<break/>*<italic>p</italic> &#x0003c; 0.05;
<break/>**<italic>p</italic> &#x0003c; 0.01; two-sided Student <italic>t</italic>-test.</title></caption><graphic xlink:href="ehp0112-001137f2"/></fig><fig id="f3-ehp0112-001137" position="float"><label>Figure 3</label><caption><title>Equivalence of biologic responses induced in the mouse uterus by E<sub>2</sub> (E), GEN (G), and DES (D). (<italic>A</italic>) Blotted uterine weights (mean &#x000b1; SD) of three independent replicate groups (1&#x02013;3) of sexually immature mice (<italic>n</italic> = 4/group) after three daily subcutaneous injections of either GEN (50 mg/kg), E<sub>2</sub> (2.5 &#x003bc;g/kg), DES (2 &#x003bc;g/kg), or AO [control (C); 5 mL/kg]. (<italic>B</italic>) Unsupervised Euclidean-distance&#x02013;based hierarchical clustering of 4,134 expressed genes. (<italic>C</italic>) Near-identical gene expression profiles induced by the three estrogens 72 hr after equipotent uterotrophic doses. Significant changes in gene expression induced by one or more of the three estrogens were identified by one-way ANOVA (parametric test, assuming equal variance). The magnitude of altered gene expression (fold change vs. vehicle control) is indicated by color.</title></caption><graphic xlink:href="ehp0112-001137f3"/></fig><table-wrap id="t1-ehp0112-001137" position="float"><label>Table 1</label><caption><p>Blotted uterine weights and endometrial and epithelial cell heights (mean &#x000b1; SD) after exposure to E<sub>2</sub>, GEN, or DES for 3 consecutive days.<xref ref-type="table-fn" rid="tfn2-ehp0112-001137"><italic><sup>a</sup></italic></xref></p></caption><table frame="hsides" rules="groups"><thead><tr valign="bottom"><th align="center" colspan="1" rowspan="1"/><th align="center" colspan="1" rowspan="1"/><th align="center" colspan="1" rowspan="1"/><th colspan="2" align="center" rowspan="1">Cell height (&#x003bc;m)
<hr/></th></tr><tr><th align="left" colspan="1" rowspan="1">Compound</th><th align="center" colspan="1" rowspan="1">Dose (per kg)</th><th align="center" colspan="1" rowspan="1">Blotted uterine weight (mg)</th><th align="center" colspan="1" rowspan="1">Endometrium</th><th align="center" colspan="1" rowspan="1">Epithelium</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">AO</td><td align="right" colspan="1" rowspan="1">5 mL</td><td align="left" colspan="1" rowspan="1">13.0 &#x000b1; 2.4</td><td align="left" colspan="1" rowspan="1">159.0 &#x000b1; 23.1 (11)</td><td align="left" colspan="1" rowspan="1">11.4 &#x000b1; 1.1</td></tr><tr><td align="left" colspan="1" rowspan="1">E<sub>2</sub></td><td align="right" colspan="1" rowspan="1">2.5 &#x003bc;g</td><td align="left" colspan="1" rowspan="1">45.3 &#x000b1; 8.6<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td><td align="left" colspan="1" rowspan="1">246.1 &#x000b1; 52.4<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref> (9)</td><td align="left" colspan="1" rowspan="1">23.3 &#x000b1; 1.4<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">GEN</td><td align="right" colspan="1" rowspan="1">50 mg</td><td align="left" colspan="1" rowspan="1">39.8 &#x000b1; 5.3<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td><td align="left" colspan="1" rowspan="1">273.7 &#x000b1; 63.3<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref> (12)</td><td align="left" colspan="1" rowspan="1">23.7 &#x000b1; 3.1<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">DES</td><td align="right" colspan="1" rowspan="1">2.0 &#x003bc;g</td><td align="left" colspan="1" rowspan="1">49.8 &#x000b1; 13.0<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td><td align="left" colspan="1" rowspan="1">273.2 &#x000b1; 55.9<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref> (10)</td><td align="left" colspan="1" rowspan="1">22.6 &#x000b1; 4.0<xref ref-type="table-fn" rid="tfn3-ehp0112-001137">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ehp0112-001137"><p>There were 12 animals/group, but not all of the histopathology samples were suitable for analyses; numbers in parentheses indicate the number of animals per group from which the histology data were generated.</p></fn><fn id="tfn2-ehp0112-001137"><label>a</label><p>Data were assessed for statistical significance using a two-sided Student <italic>t</italic>-test:</p></fn><fn id="tfn3-ehp0112-001137"><label>*</label><p><italic>p</italic> &#x0003c; 0.01.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ehp0112-001137" position="float"><label>Table 2</label><caption><p>Quantitative data for 179 differentially expressed genes (from <xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3C</xref>) regulated in the mouse uterus by all three estrogens (E<sub>2</sub>, GEN, and DES).<xref ref-type="table-fn" rid="tfn5-ehp0112-001137"><italic><sup>a</sup></italic></xref></p></caption><table frame="hsides" rules="groups"><thead><tr valign="bottom"><th align="left" colspan="1" rowspan="1"/><th align="center" colspan="1" rowspan="1"/><th colspan="3" align="center" rowspan="1">Fold change in expression (mean &#x000b1; SD)
<hr/></th></tr><tr><th align="left" colspan="1" rowspan="1">Gene name</th><th align="center" colspan="1" rowspan="1">GenBank accession no.</th><th align="center" colspan="1" rowspan="1">E<sub>2</sub></th><th align="center" colspan="1" rowspan="1">GEN</th><th align="center" colspan="1" rowspan="1">DES</th></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><bold>Up-regulated genes</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Solute carrier family 9a3r1</td><td align="left" colspan="1" rowspan="1">U74079</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.01</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Keratin complex 2&#x02013;8</td><td align="left" colspan="1" rowspan="1">X15662</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Laminin beta 3</td><td align="left" colspan="1" rowspan="1">U43298</td><td align="center" colspan="1" rowspan="1">4.3 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">5.3 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Claudin 7</td><td align="left" colspan="1" rowspan="1">AF087825</td><td align="center" colspan="1" rowspan="1">4.5 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">6.5 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">5.8 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;bHLH-Zip transcription factor</td><td align="left" colspan="1" rowspan="1">U49507</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1200008D14</td><td align="left" colspan="1" rowspan="1">AW208938</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Basic HLH-domain containing, class B2</td><td align="left" colspan="1" rowspan="1">Y07836</td><td align="center" colspan="1" rowspan="1">5.9 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">6.6 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">6.6 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 9930104H07</td><td align="left" colspan="1" rowspan="1">AW122310</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Fucosyltransferase 2</td><td align="left" colspan="1" rowspan="1">AF064792</td><td align="center" colspan="1" rowspan="1">27.5 &#x000b1; 1.2</td><td align="center" colspan="1" rowspan="1">34.6 &#x000b1; 8.5</td><td align="center" colspan="1" rowspan="1">36.7 &#x000b1; 5.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Deleted in polyposis 1</td><td align="left" colspan="1" rowspan="1">U28168</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.02</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Microsomal glutathione <italic>S</italic>-transferase 3</td><td align="left" colspan="1" rowspan="1">AI843448</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Tumor-associated Ca signal transducer 2</td><td align="left" colspan="1" rowspan="1">Y08830</td><td align="center" colspan="1" rowspan="1">4.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">4.6 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">4.6 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Calpain 5</td><td align="left" colspan="1" rowspan="1">Y10656</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">6.3 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">6.6 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Mitochondrial creatine kinase</td><td align="left" colspan="1" rowspan="1">Z13969</td><td align="center" colspan="1" rowspan="1">9.7 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">12.2 &#x000b1; 2.1</td><td align="center" colspan="1" rowspan="1">13.1 &#x000b1; 1.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;ATPase 6v1a1</td><td align="left" colspan="1" rowspan="1">AW123765</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Tumor-associated Ca signal transducer 2</td><td align="left" colspan="1" rowspan="1">AI563854</td><td align="center" colspan="1" rowspan="1">8.0 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">9.2 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">8.5 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Lymphocyte antigen 6 complex, locus A</td><td align="left" colspan="1" rowspan="1">X04653</td><td align="center" colspan="1" rowspan="1">7.8 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">8.8 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">8.5 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Chloride channel calcium-activated 3</td><td align="left" colspan="1" rowspan="1">AV373378</td><td align="center" colspan="1" rowspan="1">26.4 &#x000b1; 3.4</td><td align="center" colspan="1" rowspan="1">26.7 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">26.2 &#x000b1; 3.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2I</td><td align="left" colspan="1" rowspan="1">AJ005567</td><td align="center" colspan="1" rowspan="1">23.9 &#x000b1; 1.5</td><td align="center" colspan="1" rowspan="1">24.7 &#x000b1; 1.3</td><td align="center" colspan="1" rowspan="1">23.6 &#x000b1; 1.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Oncoprotein induced transcript 1</td><td align="left" colspan="1" rowspan="1">AA615075</td><td align="center" colspan="1" rowspan="1">19.0 &#x000b1; 3.1</td><td align="center" colspan="1" rowspan="1">20.0 &#x000b1; 1.2</td><td align="center" colspan="1" rowspan="1">18.9 &#x000b1; 2.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2F</td><td align="left" colspan="1" rowspan="1">AJ005564</td><td align="center" colspan="1" rowspan="1">59.8 &#x000b1; 8.4</td><td align="center" colspan="1" rowspan="1">65.8 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">60.6 &#x000b1; 2.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2E</td><td align="left" colspan="1" rowspan="1">AJ005563</td><td align="center" colspan="1" rowspan="1">12.0 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">12.9 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">12.1 &#x000b1; 0.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Mucin 1</td><td align="left" colspan="1" rowspan="1">M84683</td><td align="center" colspan="1" rowspan="1">8.3 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">8.6 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">8.5 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Lipoocalin 2</td><td align="left" colspan="1" rowspan="1">X81627</td><td align="center" colspan="1" rowspan="1">150.3 &#x000b1; 15.0</td><td align="center" colspan="1" rowspan="1">175.7 &#x000b1; 10.5</td><td align="center" colspan="1" rowspan="1">162.8 &#x000b1; 6.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 2210409B01</td><td align="left" colspan="1" rowspan="1">AF109906</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">4.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon-activated gene 202A</td><td align="left" colspan="1" rowspan="1">M31418</td><td align="center" colspan="1" rowspan="1">7.9 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">9.8 &#x000b1; 2.5</td><td align="center" colspan="1" rowspan="1">8.8 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Nuclear ankyrin-repeat protein</td><td align="left" colspan="1" rowspan="1">AA614971</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">4.3 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 5730469M10</td><td align="left" colspan="1" rowspan="1">AI850090</td><td align="center" colspan="1" rowspan="1">22.0 &#x000b1; 5.8</td><td align="center" colspan="1" rowspan="1">30.5 &#x000b1; 9.1</td><td align="center" colspan="1" rowspan="1">27.0 &#x000b1; 6.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1110034C02</td><td align="left" colspan="1" rowspan="1">AI837104</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;IMAGE cDNA 4988271</td><td align="left" colspan="1" rowspan="1">AV373294</td><td align="center" colspan="1" rowspan="1">8.0 &#x000b1; 2.5</td><td align="center" colspan="1" rowspan="1">10.6 &#x000b1; 1.6</td><td align="center" colspan="1" rowspan="1">9.2 &#x000b1; 1.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 5730493B19</td><td align="left" colspan="1" rowspan="1">AW122413</td><td align="center" colspan="1" rowspan="1">12.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">19.0 &#x000b1; 4.1</td><td align="center" colspan="1" rowspan="1">15.7 &#x000b1; 0.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidoglycan recognition protein</td><td align="left" colspan="1" rowspan="1">AV092014</td><td align="center" colspan="1" rowspan="1">13.4 &#x000b1; 1.5</td><td align="center" colspan="1" rowspan="1">18.3 &#x000b1; 3.0</td><td align="center" colspan="1" rowspan="1">14.5 &#x000b1; 2.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Inhibin beta-B</td><td align="left" colspan="1" rowspan="1">X69620</td><td align="center" colspan="1" rowspan="1">13.6 &#x000b1; 3.1</td><td align="center" colspan="1" rowspan="1">19.4 &#x000b1; 4.7</td><td align="center" colspan="1" rowspan="1">16.0 &#x000b1; 1.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CEA-related cell adhesion molecule 2</td><td align="left" colspan="1" rowspan="1">AF101164</td><td align="center" colspan="1" rowspan="1">11.9 &#x000b1; 1.6</td><td align="center" colspan="1" rowspan="1">17.8 &#x000b1; 5.3</td><td align="center" colspan="1" rowspan="1">14.2 &#x000b1; 1.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Keratin complex 1&#x02013;19</td><td align="left" colspan="1" rowspan="1">M36120</td><td align="center" colspan="1" rowspan="1">4.4 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">4.8 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CEA-related cell adhesion molecule 1</td><td align="left" colspan="1" rowspan="1">M77196</td><td align="center" colspan="1" rowspan="1">15.9 &#x000b1; 2.4</td><td align="center" colspan="1" rowspan="1">23.9 &#x000b1; 5.9</td><td align="center" colspan="1" rowspan="1">19.0 &#x000b1; 3.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;SRC family-associated phosphoprotein 2</td><td align="left" colspan="1" rowspan="1">AB014485</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.04</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidoglycan recognition protein</td><td align="left" colspan="1" rowspan="1">AF076482</td><td align="center" colspan="1" rowspan="1">7.7 &#x000b1; 1.9</td><td align="center" colspan="1" rowspan="1">10.4 &#x000b1; 2.7</td><td align="center" colspan="1" rowspan="1">9.0 &#x000b1; 2.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CEA-related cell adhesion molecule 1</td><td align="left" colspan="1" rowspan="1">M77196</td><td align="center" colspan="1" rowspan="1">19.5 &#x000b1; 3.9</td><td align="center" colspan="1" rowspan="1">30.4 &#x000b1; 8.8</td><td align="center" colspan="1" rowspan="1">22.2 &#x000b1; 2.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CEA-related cell adhesion molecule 1</td><td align="left" colspan="1" rowspan="1">X67279</td><td align="center" colspan="1" rowspan="1">6.4 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">8.4 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">7.1 &#x000b1; 1.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Spermidine N1-acetyl transferase</td><td align="left" colspan="1" rowspan="1">L10244</td><td align="center" colspan="1" rowspan="1">8.3 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">11.2 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">9.3 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 0610007O07</td><td align="left" colspan="1" rowspan="1">AI851762</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Arginase 1</td><td align="left" colspan="1" rowspan="1">U51805</td><td align="center" colspan="1" rowspan="1">79.4 &#x000b1; 9.8</td><td align="center" colspan="1" rowspan="1">131.9 &#x000b1; 20.0</td><td align="center" colspan="1" rowspan="1">99.6 &#x000b1; 14.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Acetyl-coenzyme A synthetase 2</td><td align="left" colspan="1" rowspan="1">AW125884</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;<italic>v-erb</italic>-b2 homolog 3</td><td align="left" colspan="1" rowspan="1">AI006228</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Phospholipase D3</td><td align="left" colspan="1" rowspan="1">AF026124</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 0610031J06</td><td align="left" colspan="1" rowspan="1">AW122935</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Complement component 1q</td><td align="left" colspan="1" rowspan="1">X58861</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Scotin</td><td align="left" colspan="1" rowspan="1">AW123754</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CD24a antigen</td><td align="left" colspan="1" rowspan="1">M58661</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Argininosuccinate synthetase 1</td><td align="left" colspan="1" rowspan="1">M31690</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;ATPase 6v1a1</td><td align="left" colspan="1" rowspan="1">U13837</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Gelsolin-like actin-capping protein</td><td align="left" colspan="1" rowspan="1">X54511</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Golgi phosphoprotein 2</td><td align="left" colspan="1" rowspan="1">AW125446</td><td align="center" colspan="1" rowspan="1">4.5 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.6 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.7 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Aldolase 1A</td><td align="left" colspan="1" rowspan="1">Y00516</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cathepsin L</td><td align="left" colspan="1" rowspan="1">X06086</td><td align="center" colspan="1" rowspan="1">6.4 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">6.3 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">6.9 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CD14 antigen</td><td align="left" colspan="1" rowspan="1">X13333</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Decay accelerating factor 2</td><td align="left" colspan="1" rowspan="1">L41365</td><td align="center" colspan="1" rowspan="1">4.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Actin-related protein 2/3 complex 1B</td><td align="left" colspan="1" rowspan="1">AW212775</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Protective protein for &#x003b2;-galactosidase</td><td align="left" colspan="1" rowspan="1">J05261</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0&#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Elastase 1</td><td align="left" colspan="1" rowspan="1">M27347</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Connexin 26</td><td align="left" colspan="1" rowspan="1">M81445</td><td align="center" colspan="1" rowspan="1">10.6 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">9.8 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">10.4 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Ceruloplasmin</td><td align="left" colspan="1" rowspan="1">U49430</td><td align="center" colspan="1" rowspan="1">15.1 &#x000b1; 2.8</td><td align="center" colspan="1" rowspan="1">15.0 &#x000b1; 5.5</td><td align="center" colspan="1" rowspan="1">14.5 &#x000b1; 2.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cathepsin H</td><td align="left" colspan="1" rowspan="1">U06119</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Basigin</td><td align="left" colspan="1" rowspan="1">Y16258</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidylprolyl isomerase C&#x02013;associated</td><td align="left" colspan="1" rowspan="1">X67809</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Glutathione reductase 1</td><td align="left" colspan="1" rowspan="1">AI851983</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;START domain&#x02013;containing 3</td><td align="left" colspan="1" rowspan="1">X82457</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.4 &#x000b1; 0.03</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CD68 antigen</td><td align="left" colspan="1" rowspan="1">X68273</td><td align="center" colspan="1" rowspan="1">4.6 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">5.0 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA E030027H19</td><td align="left" colspan="1" rowspan="1">AW211760</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;cDNA sequence BC004044</td><td align="left" colspan="1" rowspan="1">AI461767</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;E74-like factor 3</td><td align="left" colspan="1" rowspan="1">AF016294</td><td align="center" colspan="1" rowspan="1">5.1 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">5.9 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">6.5 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Glutathione <italic>S</italic>-transferase omega 1</td><td align="left" colspan="1" rowspan="1">AI843119</td><td align="center" colspan="1" rowspan="1">5.0 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">4.6 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon-stimulated protein 20</td><td align="left" colspan="1" rowspan="1">AW122677</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">4.3 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Clusterin</td><td align="left" colspan="1" rowspan="1">D14077</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">3.9 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Galectin 3</td><td align="left" colspan="1" rowspan="1">X16834</td><td align="center" colspan="1" rowspan="1">7.4 &#x000b1; 1.3</td><td align="center" colspan="1" rowspan="1">8.7 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">6.9 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2A<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">AJ005559</td><td align="center" colspan="1" rowspan="1">51.1 &#x000b1; 4.0</td><td align="center" colspan="1" rowspan="1">78.3 &#x000b1; 15.7</td><td align="center" colspan="1" rowspan="1">44.2 &#x000b1; 5.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Complement component 3<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">K02782</td><td align="center" colspan="1" rowspan="1">14.8 &#x000b1; 1.8</td><td align="center" colspan="1" rowspan="1">18.8 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">14.8 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2C</td><td align="left" colspan="1" rowspan="1">AJ005561</td><td align="center" colspan="1" rowspan="1">220.3&#x000b1; 31.0</td><td align="center" colspan="1" rowspan="1">340.5 &#x000b1; 37.1</td><td align="center" colspan="1" rowspan="1">214.1 &#x000b1; 41.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2G</td><td align="left" colspan="1" rowspan="1">AJ005565</td><td align="center" colspan="1" rowspan="1">9.4 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">11.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">9.6 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Prominin</td><td align="left" colspan="1" rowspan="1">AF039663</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Lactotransferrin<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">J03298</td><td align="center" colspan="1" rowspan="1">88.7 &#x000b1; 18.4</td><td align="center" colspan="1" rowspan="1">99.2 &#x000b1; 13.9</td><td align="center" colspan="1" rowspan="1">76.9 &#x000b1; 21.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Carbonic anhydrase 2</td><td align="left" colspan="1" rowspan="1">M25944</td><td align="center" colspan="1" rowspan="1">7.9 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">8.2 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">7.3 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Complement component factor I</td><td align="left" colspan="1" rowspan="1">U47810</td><td align="center" colspan="1" rowspan="1">36.5 &#x000b1; 4.4</td><td align="center" colspan="1" rowspan="1">38.4 &#x000b1; 5.6</td><td align="center" colspan="1" rowspan="1">32.9 &#x000b1; 4.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Mannosidase 2alphaB1</td><td align="left" colspan="1" rowspan="1">U87240</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2B</td><td align="left" colspan="1" rowspan="1">AJ005560</td><td align="center" colspan="1" rowspan="1">32.9 &#x000b1; 3.7</td><td align="center" colspan="1" rowspan="1">39.2 &#x000b1; 1.9</td><td align="center" colspan="1" rowspan="1">30.7 &#x000b1; 5.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2A<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">AJ005559</td><td align="center" colspan="1" rowspan="1">269.8 &#x000b1; 23.7</td><td align="center" colspan="1" rowspan="1">329.1 &#x000b1; 42.9</td><td align="center" colspan="1" rowspan="1">59.1 &#x000b1; 40.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 5830413E08</td><td align="left" colspan="1" rowspan="1">AI849939</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1110029F20</td><td align="left" colspan="1" rowspan="1">AW125508</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Annexin A3</td><td align="left" colspan="1" rowspan="1">AJ001633</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidase 4</td><td align="left" colspan="1" rowspan="1">U51014</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Laminin gamma 2</td><td align="left" colspan="1" rowspan="1">U43327</td><td align="center" colspan="1" rowspan="1">6.3 &#x000b1; 1.3</td><td align="center" colspan="1" rowspan="1">17.3 &#x000b1; 6.8</td><td align="center" colspan="1" rowspan="1">10.2 &#x000b1; 1.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Ubiquitin-like 3</td><td align="left" colspan="1" rowspan="1">AW120725</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Urate oxidase</td><td align="left" colspan="1" rowspan="1">M27695</td><td align="center" colspan="1" rowspan="1">23.8 &#x000b1; 9.5</td><td align="center" colspan="1" rowspan="1">143.9 &#x000b1; 62.9</td><td align="center" colspan="1" rowspan="1">43.8 &#x000b1;17.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Amiloride binding protein 1</td><td align="left" colspan="1" rowspan="1">AI197481</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">10.1 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">6.0 &#x000b1; 1.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Keratin complex 1&#x02013;19</td><td align="left" colspan="1" rowspan="1">AU040563</td><td align="center" colspan="1" rowspan="1">4.5 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">7.2 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">5.6 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Activated leukocyte cell adhesion molecule</td><td align="left" colspan="1" rowspan="1">L25274</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">5.1 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">4.4 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;CCAAT/enhancer binding protein &#x003b2;</td><td align="left" colspan="1" rowspan="1">M61007</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidyl arginine deiminase, type I</td><td align="left" colspan="1" rowspan="1">AB013848</td><td align="center" colspan="1" rowspan="1">8.6 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">15.8 &#x000b1; 3.1</td><td align="center" colspan="1" rowspan="1">12.0 &#x000b1; 1.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Enolase 1 &#x003b1;</td><td align="left" colspan="1" rowspan="1">AI841389</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;<italic>p53</italic> apoptosis effector related to <italic>Pmp22</italic></td><td align="left" colspan="1" rowspan="1">AI854029</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;&#x003b2;-Glucuronidase</td><td align="left" colspan="1" rowspan="1">M19279</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Leucine-rich &#x003b1;-2-glycoprotein</td><td align="left" colspan="1" rowspan="1">AW230891</td><td align="center" colspan="1" rowspan="1">9.3 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">17.6 &#x000b1; 4.1</td><td align="center" colspan="1" rowspan="1">14.5 &#x000b1; 2.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Quiescin Q6</td><td align="left" colspan="1" rowspan="1">AW123556</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 1.2</td><td align="center" colspan="1" rowspan="1">4.8 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;GADD45a</td><td align="left" colspan="1" rowspan="1">U00937</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Alkaline phosphatase 2</td><td align="left" colspan="1" rowspan="1">J02980</td><td align="center" colspan="1" rowspan="1">9.2 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">22.6 &#x000b1; 6.2</td><td align="center" colspan="1" rowspan="1">15.8 &#x000b1; 2.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Immediate early response 3</td><td align="left" colspan="1" rowspan="1">X67644</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">10.8 &#x000b1; 2.2</td><td align="center" colspan="1" rowspan="1">8.9 &#x000b1; 2.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Progressive ankylosis</td><td align="left" colspan="1" rowspan="1">AW049351</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RAS p21 protein activator 4</td><td align="left" colspan="1" rowspan="1">AA163960</td><td align="center" colspan="1" rowspan="1">6.8 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">14.2 &#x000b1; 2.5</td><td align="center" colspan="1" rowspan="1">12.1 &#x000b1; 1.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Tumor-associated calcium signal transducer 1</td><td align="left" colspan="1" rowspan="1">M76124</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Hydroxysteroid (17-beta) dehydrogenase 11</td><td align="left" colspan="1" rowspan="1">AA822174</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Platelet-activating factor acetylhydrolase 1ba1</td><td align="left" colspan="1" rowspan="1">U57746</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Branched chain aminotransferase 1</td><td align="left" colspan="1" rowspan="1">U42443</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 2400004E04</td><td align="left" colspan="1" rowspan="1">AI846720</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Myeloblastosis oncogene</td><td align="left" colspan="1" rowspan="1">M12848</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">5.6 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">5.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;K<sup>+</sup> conductance calcium-activated channel N4</td><td align="left" colspan="1" rowspan="1">AF042487</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;ATPase 6v1b2</td><td align="left" colspan="1" rowspan="1">AI843029</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cystic fibrosis transmembrane regulator</td><td align="left" colspan="1" rowspan="1">M60493</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.5 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">3.9 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1110008P14</td><td align="left" colspan="1" rowspan="1">AI839839</td><td align="center" colspan="1" rowspan="1">4.3 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">6.0 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">5.1 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Fused toes</td><td align="left" colspan="1" rowspan="1">Z67963</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Solute carrier family 39a8</td><td align="left" colspan="1" rowspan="1">AW124340</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.5 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cytochrome b-561</td><td align="left" colspan="1" rowspan="1">AI846517</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Secreted phosphoprotein 1</td><td align="left" colspan="1" rowspan="1">X13986</td><td align="center" colspan="1" rowspan="1">30.2 &#x000b1; 3.3</td><td align="center" colspan="1" rowspan="1">47.4 &#x000b1; 7.4</td><td align="center" colspan="1" rowspan="1">31.1 &#x000b1; 2.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Ion transport regulator Fxyd3</td><td align="left" colspan="1" rowspan="1">X93038</td><td align="center" colspan="1" rowspan="1">5.3 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">6.8 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">5.5 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Janus kinase 3</td><td align="left" colspan="1" rowspan="1">L40172</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cytochrome b-245alpha</td><td align="left" colspan="1" rowspan="1">AW046124</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA A430096B05</td><td align="left" colspan="1" rowspan="1">AI465965</td><td align="center" colspan="1" rowspan="1">6.3 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">8.6 &#x000b1; 0.03</td><td align="center" colspan="1" rowspan="1">6.3 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 2J</td><td align="left" colspan="1" rowspan="1">AJ005568</td><td align="center" colspan="1" rowspan="1">8.6 &#x000b1; 2.1</td><td align="center" colspan="1" rowspan="1">13.8 &#x000b1; 3.2</td><td align="center" colspan="1" rowspan="1">8.5 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cathepsin B</td><td align="left" colspan="1" rowspan="1">M65270</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1600025H15</td><td align="left" colspan="1" rowspan="1">AI842734</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;c-<italic>fos</italic> oncogene<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">V00727</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">4.7 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Guanine nucleotide binding protein &#x003b3;5</td><td align="left" colspan="1" rowspan="1">AI843937</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Serine palmitoyltransferase lc2</td><td align="left" colspan="1" rowspan="1">U27455</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cystatin B</td><td align="left" colspan="1" rowspan="1">U59807</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.02</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Villin 2</td><td align="left" colspan="1" rowspan="1">X60671</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 0610010O12</td><td align="left" colspan="1" rowspan="1">AI849011</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Matrix metalloproteinase 7</td><td align="left" colspan="1" rowspan="1">L36244</td><td align="center" colspan="1" rowspan="1">47.8 &#x000b1; 18.6</td><td align="center" colspan="1" rowspan="1">208.6 &#x000b1; 83.3</td><td align="center" colspan="1" rowspan="1">48.2 &#x000b1; 11.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 4930422J18</td><td align="left" colspan="1" rowspan="1">AV376312</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1700017B05</td><td align="left" colspan="1" rowspan="1">AW049360</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Galactosidase beta 1</td><td align="left" colspan="1" rowspan="1">M57734</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Cathepsin C</td><td align="left" colspan="1" rowspan="1">U74683</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon-stimulated protein 15</td><td align="left" colspan="1" rowspan="1">X56602</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;MAP kinase&#x02013;interacting kinase 2</td><td align="left" colspan="1" rowspan="1">Y11092</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.4 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Glutathione <italic>S</italic>-transferase theta 2</td><td align="left" colspan="1" rowspan="1">X98056</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.4</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Gene name</td><td align="left" colspan="1" rowspan="1">accession no.</td><td align="center" colspan="1" rowspan="1">E<sub>2</sub></td><td align="center" colspan="1" rowspan="1">GEN</td><td align="center" colspan="1" rowspan="1">DES</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Homeobox B6</td><td align="left" colspan="1" rowspan="1">M18401</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.02</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Procollagen VIalpha 3</td><td align="left" colspan="1" rowspan="1">AF064749</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.02</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon regulatory factor 7</td><td align="left" colspan="1" rowspan="1">U73037</td><td align="center" colspan="1" rowspan="1">11.7 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">8.1 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">12.6 &#x000b1; 1.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Scavenger receptor class B2</td><td align="left" colspan="1" rowspan="1">AB008553</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.4 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Polyimmunoglobulin receptor</td><td align="left" colspan="1" rowspan="1">AB001489</td><td align="center" colspan="1" rowspan="1">8.1 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">6.2 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">7.9 &#x000b1; 1.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Proteasome subunit &#x003b2;10</td><td align="left" colspan="1" rowspan="1">Y10875</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.04</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.04</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 0610010E05</td><td align="left" colspan="1" rowspan="1">AV312736</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 0610010E05</td><td align="left" colspan="1" rowspan="1">AI854839</td><td align="center" colspan="1" rowspan="1">3.7 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">3.4 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Xanthine dehydrogenase</td><td align="left" colspan="1" rowspan="1">X75129</td><td align="center" colspan="1" rowspan="1">12.2 &#x000b1; 2.2</td><td align="center" colspan="1" rowspan="1">8.9 &#x000b1; 1.2</td><td align="center" colspan="1" rowspan="1">10.1 &#x000b1; 1.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Prominin</td><td align="left" colspan="1" rowspan="1">AF039663</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon-induced protein IFIT1</td><td align="left" colspan="1" rowspan="1">U43084</td><td align="center" colspan="1" rowspan="1">17.5 &#x000b1; 2.9</td><td align="center" colspan="1" rowspan="1">9.9 &#x000b1; 1.5</td><td align="center" colspan="1" rowspan="1">14.0 &#x000b1; 2.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Interferon-induced protein IFIT3</td><td align="left" colspan="1" rowspan="1">U43086</td><td align="center" colspan="1" rowspan="1">8.1 &#x000b1; 2.3</td><td align="center" colspan="1" rowspan="1">4.7 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">6.7 &#x000b1; 0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Proteasome subunit &#x003b2;8</td><td align="left" colspan="1" rowspan="1">U22033</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA 1600023A02</td><td align="left" colspan="1" rowspan="1">AW121336</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.04</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Small proline-rich protein 1A</td><td align="left" colspan="1" rowspan="1">AF057156</td><td align="center" colspan="1" rowspan="1">11.1 &#x000b1; 3.7</td><td align="center" colspan="1" rowspan="1">8.6 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">14.7 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;MAP kinase-interacting kinase 2</td><td align="left" colspan="1" rowspan="1">AI845732</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Lymphocyte antigen 6 complex, locus E</td><td align="left" colspan="1" rowspan="1">U47737</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.01</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Guanylate nucleotide binding protein 2</td><td align="left" colspan="1" rowspan="1">AJ007970</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.6 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Peptidyl arginine deiminase, type II<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">D16580</td><td align="center" colspan="1" rowspan="1">1.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">9.1 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">5.2 &#x000b1; 1.5</td></tr><tr><td colspan="5" align="left" rowspan="1"><bold>Down-regulated genes</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Solute carrier family 29a1</td><td align="left" colspan="1" rowspan="1">AI838274</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.9 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Lymphocyte specific 1</td><td align="left" colspan="1" rowspan="1">D49691</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Claudin 5</td><td align="left" colspan="1" rowspan="1">U82758</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Potassium channel td12</td><td align="left" colspan="1" rowspan="1">AI842065</td><td align="center" colspan="1" rowspan="1">1.6 &#x000b1; 0.04</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.04</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Zinc finger homeobox 1a</td><td align="left" colspan="1" rowspan="1">D76432</td><td align="center" colspan="1" rowspan="1">1.5 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.7 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Monoamine oxidase A</td><td align="left" colspan="1" rowspan="1">AI848045</td><td align="center" colspan="1" rowspan="1">2.3 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.7 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Histidine decarboxylase</td><td align="left" colspan="1" rowspan="1">X57437</td><td align="center" colspan="1" rowspan="1">4.8 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">7.1 &#x000b1; 0.6</td><td align="center" colspan="1" rowspan="1">5.4 &#x000b1; 0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;&#x003b1;-2 Adrenergic receptor</td><td align="left" colspan="1" rowspan="1">M97516</td><td align="center" colspan="1" rowspan="1">3.0 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 1.1</td><td align="center" colspan="1" rowspan="1">3.6 &#x000b1; 0.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Transcription factor 21</td><td align="left" colspan="1" rowspan="1">AF035717</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">2.0 &#x000b1; 0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Homeobox D8</td><td align="left" colspan="1" rowspan="1">X56561</td><td align="center" colspan="1" rowspan="1">2.2 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.8 &#x000b1; 0.03</td><td align="center" colspan="1" rowspan="1">2.5 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Carboxypeptidase X2</td><td align="left" colspan="1" rowspan="1">AF017639</td><td align="center" colspan="1" rowspan="1">4.1 &#x000b1; 0.7</td><td align="center" colspan="1" rowspan="1">5.2 &#x000b1; 1.0</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;RIKEN cDNA A230106A15</td><td align="left" colspan="1" rowspan="1">AI848841</td><td align="center" colspan="1" rowspan="1">3.8 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">4.7 &#x000b1; 0.5</td><td align="center" colspan="1" rowspan="1">4.2 &#x000b1; 0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Reduced expression 3</td><td align="left" colspan="1" rowspan="1">AA790008</td><td align="center" colspan="1" rowspan="1">3.1 &#x000b1; 0.2</td><td align="center" colspan="1" rowspan="1">3.5 &#x000b1; 0.3</td><td align="center" colspan="1" rowspan="1">3.2 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;TGF-&#x003b2; binding protein 4</td><td align="left" colspan="1" rowspan="1">AA838868</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">2.1 &#x000b1; 0.1</td><td align="center" colspan="1" rowspan="1">1.8 &#x000b1; 0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;Keratoepithelin<xref ref-type="table-fn" rid="tfn6-ehp0112-001137"><italic><sup>b</sup></italic></xref></td><td align="left" colspan="1" rowspan="1">L19932</td><td align="center" colspan="1" rowspan="1">11.5 &#x000b1; 2.5</td><td align="center" colspan="1" rowspan="1">12.6 &#x000b1; 0.9</td><td align="center" colspan="1" rowspan="1">9.7 &#x000b1; 3.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#x02003;GLI-Kruppel family member GLI</td><td align="left" colspan="1" rowspan="1">AB025922</td><td align="center" colspan="1" rowspan="1">11.6 &#x000b1; 0.8</td><td align="center" colspan="1" rowspan="1">12.2 &#x000b1; 2.6</td><td align="center" colspan="1" rowspan="1">8.2 &#x000b1; 2.6</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-ehp0112-001137"><p>Abbreviations: CEA, carcinoembrionary antigen; SRC, steroid receptor coactivator; TGF, transforming growth factor.</p></fn><fn id="tfn5-ehp0112-001137"><label>a</label><p>Gene names (derived from the NetAffx database; <xref ref-type="bibr" rid="b20-ehp0112-001137">Liu et al. 2003</xref>), GenBank accession numbers (<xref ref-type="bibr" rid="b12-ehp0112-001137">GenBank 2004</xref>), and mean (&#x000b1; SD) fold induction/repression of gene expression are shown in the same order as the gene cluster in <xref ref-type="fig" rid="f3-ehp0112-001137">Figure 3C</xref>.</p></fn><fn id="tfn6-ehp0112-001137"><label>b</label><p>Genes mentioned in the text.</p></fn></table-wrap-foot></table-wrap></floats-group></article>